FdaApplication

ANDA 206765

Back to search

Identifiers

Properties

PropertyValue
applicant_nameALKEM LABORATORIES LTD
application_typeANDA
approval_date2018-07-30

Products (1)

ProductActive ingredientStrengthDosage form
DALFAMPRIDINEDALFAMPRIDINE10MGTABLET, EXTENDED RELEASE;ORAL

1 product